Please provide your email address to receive an email when new articles are posted on . Noninvasive gene expression testing by DermTech detects melanoma equally in all Fitzpatrick skin types. The test ...
(RTTNews) - Arcutis Biotherapeutics Inc.'s (ARQT) ZORYVE cream 0.15% provided consistent and meaningful improvements in signs and symptoms of atopic dermatitis in individuals regardless of race, ...
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results